DCC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DCC Antibodies for advanced research in molecular biology. DCC Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DCC, or Deleted in Colorectal Carcinoma, plays a crucial role in neuronal guidance and tumor suppression. DCC's involvement in mediating cell signaling pathways makes it essential for understanding developmental processes and cancer biology. Research focusing on DCC has revealed significant implications in colorectal cancer, where expression levels impact tumor progression and patient outcomes. Investigating DCC expression patterns helps researchers understand its role in both normal development and disease states. Advanced detection methods enable precise visualization and quantification of DCC in various cellular compartments. Ongoing studies continue to uncover new functions of DCC in neural development and cancer progression. Santa Cruz Biotechnology monoclonal antibodies for DCC support researchers worldwide in advancing scientific understanding of cancer biology and neuroscience.